MADISON, N.J. -- Health insurer Humana is selling a toxicology and clinical lab business, a division of its Concentra health care provider, to Quest Diagnostics Inc.
Quest, a medical lab operator, did not say Thursday how much it had paid for the business, which includes a lab in Memphis, Tenn. It's the company's third laboratory acquisition this year. Quest also said Thursday that it signed a long-term deal that makes it the main provider of workplace drug toxicology and clinical lab testing for Concentra.
Quest does not expect an impact to its 2013 adjusted earnings per share from the deal, but it does see a modest benefit next year.
The Madison, N.J., company's first-quarter net income fell 15 percent as people cut back on medical spending and more Medicare reimbursements cut into revenue.
Shares of Quest added 13 cents to $60.12 in afternoon trading, while Humana's stock fell 39 cents to $79.11.
Copyright:
(c) 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Advisor News
- Guaranteed income streams help preserve assets later in retirement
- Economic pressures make boomerang living the new normal
- Pay or Die: The scare tactics behind LA County’s Measure ER tax increase
- How to listen to what your client isn’t saying
- Strong underwriting: what it means for insurers and advisors
More Advisor NewsAnnuity News
- Guaranteed income streams help preserve assets later in retirement
- MassMutual turns 175, Marking Generations of Delivering on its Commitments
- ALIRT Insurance Research: U.S. Life Insurance Industry In Transition
- My Annuity Store Launches a Free AI Annuity Research Assistant Trained on 146 Carrier Brochures and Live Annuity Rates
- Ameritas settles with Navy vet in lawsuit over disputed annuity sale
More Annuity NewsHealth/Employee Benefits News
- Judge rules some evidence admissible in Luigi Mangione murder case
- New cap on split costs for patients
- Researchers from University of South Carolina Provide Details of New Studies and Findings in the Area of Opioids (Trends in Medicaid managed care benefits for opioid use disorder treatment, 2015-2019): Opioids
- State lawmakers push bill to stop insurance termination based on genetic tests
- CMS rule cracks down on ACA fraud and strengthens state control
More Health/Employee Benefits NewsLife Insurance News
- Best’s Market Segment Report: AM Best Revises Outlook on France’s Non-Life Insurance Segment to Stable from Negative, Reflecting Top-line Growth, Technical Profitability
- Pacific Life Launches New Flagship Variable Universal Life Insurance Product
- NAIFA launches “NAIFA Cares” initiative to help build long-term financial security for children
- The fiduciary standard for life insurance is here
- GenAI: Moving to the forefront of claims management
More Life Insurance News